Intercellular Adhesion Molecule 3: Structure, Cellular Functions, and Emerging Role in Human Diseases

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Intercellular adhesion molecule 3 (ICAM3/CD50) is a leukocyte-expressed transmembrane glycoprotein.
• It functions as a key ligand for lymphocyte function-associated antigen-1 (LFA-1), critical for initiating immune responses.
• Emerging evidence links ICAM3 to the pathogenesis of diverse diseases, including cancers.

Purpose of the Study:

• To review the genomic localization, protein structure, and fundamental functions of ICAM3.
• To discuss ICAM3's role in immune cell function and its association with various diseases.
• To explore ICAM3's regulatory impact on malignant cancer progression and related signaling pathways.

Main Methods:

• Literature review and synthesis of existing research on ICAM3.
• Analysis of ICAM3's genomic and structural characteristics.
• Discussion of ICAM3's functional roles in immunity and disease pathogenesis.

Main Results:

• ICAM3 is constitutively expressed in leukocytes and is a primary LFA-1 ligand.
• ICAM3 is implicated in the pathogenesis of multiple diseases and influences cancer progression.
• ICAM3 signaling pathways are involved in malignant transformations.

Conclusions:

• ICAM3 holds potential as a diagnostic molecular marker for human diseases and cancers.
• Targeting ICAM3, possibly with small molecule inhibitors, may offer new therapeutic strategies for related diseases and cancers.